DyeVert™ System for Contrast Monitoring in At-Risk Patients Undergoing Angiography: A Real-World Registry (DyeMINISH)
DyeVert™ System Use for Contrast Monitoring and Minimization in At-Risk Patients Undergoing Angiography Procedures: A Real-World Registry (DyeMINISH Registry)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Locations
-
-
Connecticut
-
Hartford, Connecticut, United States, 06102
- Hartford Healthcare
-
-
Florida
-
Hialeah, Florida, United States, 33016
- Steward Palmetto General Hospital
-
-
Georgia
-
Atlanta, Georgia, United States, 30322
- Emory Healthcare
-
Decatur, Georgia, United States, 30033
- Atlanta VA Medical Center
-
-
Kansas
-
Overland Park, Kansas, United States, 66211
- Midwest Heart & Vascular Specialists
-
-
Kentucky
-
Edgewood, Kentucky, United States, 41017
- St. Elizabeth Healthcare
-
-
Mississippi
-
Tupelo, Mississippi, United States, 38801
- North Mississippi Medical Center
-
-
Texas
-
San Antonio, Texas, United States, 78229
- The University of Texas Health Science Center
-
San Antonio, Texas, United States, 78251
- CHRISTUS Health-Westover Hills
-
-
West Virginia
-
Huntington, West Virginia, United States, 25702
- St. Mary's Medical Center
-
Morgantown, West Virginia, United States, 26506
- West Virginia University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- DyeVert Group Patients: Patient underwent a diagnostic and/or interventional angiography procedure in which the DyeVert System was used in a majority of the case
- Patient is willing and able to provide appropriate informed consent (if required)
Exclusion Criteria:
- Required data was not collected or is not available
- In the Investigator or Sponsor's opinion, the patient is not considered to be suitable
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Evaluate contrast media volume (CMV) threshold setting practices and contrast media (CM) usage during index cath lab procedures in which the DyeVert System was used
Time Frame: Index procedure
|
Index procedure
|
|
Evaluate incidence of adverse events associated with index cath lab procedures in which the DyeVert System was used
Time Frame: Index procedure through 120 days post index procedure
|
Index procedure through 120 days post index procedure
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Anand Prasad, MD, FACC, UT Health Science Center San Antonio: Prof of Medicine & Director Cardiac Catheterization Laboratory
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ANTICIPATED)
Primary Completion
Study Completion (ANTICIPATED)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- TP-6647
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.